Pax Healthcare

What Pax Healthcare does

Pax Healthcare Pvt Limited is an Indian pharmaceutical company founded in 2006 and headquartered in Chandigarh, operating as a PCD (Propaganda-Cum-Distribution) pharma franchise platform. It manufactures and distributes a portfolio of 500+ branded generic formulations across 15+ therapeutic segments — including antibiotics, antifungals, NSAIDs, gastrointestinal, cardiovascular, dermatology, neurology, gynecology, ophthalmology, ENT, orthopedics, critical care, pediatric, nutraceutical, and cardiac-diabetic — organized into dosage-form lines (tablets, capsules, syrups, dry syrups, injectables, topicals, eye/ear drops, sachets, protein powders, dentals) and dedicated veterinary (Pax Vetmed) and Ayurvedic divisions.

Production is anchored by four wholly-owned WHO-GMP, ISO 9001:2008/2015, GMP, and DCGI-certified manufacturing units in the excise-free zones of Baddi (Himachal Pradesh) and Jammu & Kashmir, operated through DM Pharma Pvt Ltd., Rainbow Humancare Pvt Ltd., Vinca LifeSciences, and DM Pharma (Jammu). R&D centers support formulation development and a rolling launch pipeline of new molecules. The company uses standardized ALU-ALU blister packaging and follows Schedule M, SOPs, and approved-supplier raw-material testing.

The business model is built on a monopoly-based PCD franchise channel granting district-level exclusive distribution rights to 1200-1500+ associate distributors across India, supplemented by direct and indirect distributors, third-party/contract manufacturing for large multinational pharma companies, and direct exports to Nepal, Afghanistan, and Australia. Franchisees invest ₹25,000-₹1,50,000+ depending on scale, place recurring reorders at 20-40% margins, and are supported with free promotional kits, MR training, and 24-hour dispatch. Demand generation is driven primarily by SEO-optimized state-wise landing pages, blog content, WhatsApp, phone, and email inside sales, with awards (UDYOG PATRA AWARD) and franchise testimonials as social proof.

Name

Pax Healthcare

Legal name

Pax Healthcare Pvt Limited

Website

https://paxhealthcare.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Pax Healthcare is an Indian pharmaceutical company founded in 2006 that manufactures 500+ branded generic formulations across 15+ therapeutic segments and distributes them nationwide through a monopoly-based PCD franchise network of 1200-1500+ associate distributors, with exports to Nepal, Afghanistan, and Australia.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Surgical and Medical Instrument Manufacturing (339112)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• PCD pharma franchise
• Pharmaceutical manufacturing
• Generic formulations
• Pharma distribution
• Contract manufacturing

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. PCD Pharma Franchise Product Distribution: Core revenue stream. Pharmaceutical products are sold at distributor/stockist and retail margins to a network of 1200–1500+ franchise associates across India, who in turn sell to chemists, hospitals, and doctors in allotted monopoly territories. Franchisees typically place recurring orders with margins of 20–40%.
2. Third-Party / Contract Manufacturing: Contract manufacturing services supplied from Pax Healthcare's 4 owned production units in Baddi and Jammu & Kashmir to large multinational pharmaceutical companies, leveraging WHO-GMP and Schedule-M compliant capacity.
3. Pharmaceutical Exports: Export of branded generic formulations to international markets including Nepal, Afghanistan, and Australia via direct shipping and overseas distributor relationships.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels6 records

Core offering

Pax Healthcare manufactures pharmaceutical formulations across multiple dosage forms through four WHO-GMP certified manufacturing units located in Baddi (Himachal Pradesh) and Jammu & Kashmir. The company distributes its products primarily through a monopoly-based PCD pharma franchise model across India and provides third-party contract manufacturing services for multinational pharmaceutical companies.

Product overview

Pax Healthcare operates as a multi-product PCD (Propaganda-Cum-Distribution) pharma franchise platform rather than a single unified product. Its core offering is the PCD Pharma Franchise, under which it distributes a portfolio of 500+ branded pharmaceutical formulations organized along two dimensions: dosage-form lines (Tablet Range, Capsule Range, Liquids/Syrups, Dry Syrups, Drops, Eye Drops, Topicals/Derma, Dental, Sachet, Protein Powder, Injections, Herbal/Ayurvedic) and therapeutic franchise ranges (Neuro, General Medicine, Antibiotic, Pediatric, Nutritional & Food Supplement, Derma, Gynae, Nutraceutical, Ortho, Critical Care, ENT, Ophthalmic, Cardiac Diabetic). Two dedicated divisions sit alongside the allopathic portfolio — Pax Vetmed (Veterinary Medicine) and the Ayurvedic Range — and the company also offers Third-Party Pharma Manufacturing to other brands and MNCs using its four WHO-GMP-certified units (DM Pharma Pvt Ltd., Rainbow Humancare Pvt Ltd., Vinca LifeSciences and DM Pharma Jammu). Named flagship SKUs across these lines include Aceper-Cold, Clarpax, Clausigerm, Crinux-O LB, Dermirose, Lezopax, Pax-Good, Paxnom 9G, Pelcin-DS, Perox-CV, Silopax-8, Uti-Not, OTIGOOD EAR DROP, VOVILEP GEL and Bilapax-M, among others.

Differentiator

Problem solved

Functional benefit

Brands

• Pax Vetmed: Veterinary medicine division of Pax Healthcare
• Ayurvedic Range

Products and services

• PCD Pharma Franchise A monopoly-based franchise distribution offering that allows pharmaceutical distributors, stockists, and medical representatives to sell Pax Healthcare's product range in designated territories across India. Targets pharma entrepreneurs seeking low-investment entry into pharma distribution.
• Third-Party Manufacturing Services Contract manufacturing services provided to multinational pharmaceutical companies, leveraging Pax Healthcare's WHO-GMP certified production capacity across its four manufacturing units in Baddi and Jammu & Kashmir.

Quantifiable outcome

• 1200–1500+ channel partner network across India
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• DM Pharma Pvt Ltd.coreOEM/ Whitelabel/ Licensing PartnerOne of Pax Healthcare's four owned manufacturing units, located in Baddi (Himachal Pradesh). Operates in an excise-free zone per Schedule M and WHO-GMP guidelines and supplies Pax Healthcare's branded generic formulations. Listed as a sister/affiliated entity in Pax Healthcare's 'Our Divisions' section.
• Rainbow Humancare Pvt Ltd.coreOEM/ Whitelabel/ Licensing PartnerOne of Pax Healthcare's four owned manufacturing units in Baddi (Himachal Pradesh), operating in an excise-free zone to support bulk DCGI-approved production.
• Vinca LifeSciencescoreOEM/ Whitelabel/ Licensing PartnerOne of Pax Healthcare's four owned manufacturing units in Baddi (Himachal Pradesh), operating in the excise-free zone per Schedule M and WHO-GMP standards.
• DM Pharma (Jammu)coreOEM/ Whitelabel/ Licensing PartnerOne of Pax Healthcare's four owned manufacturing units, located in Jammu (Jammu & Kashmir), within an excise-free zone. Supports bulk WHO-GMP production for the Pax Healthcare portfolio.
• Edward Young LabsminorStrategic or Co-development PartnerAffiliated/sister pharma company in Pax Healthcare's 'Our Divisions' ecosystem. Edward Young Labs is separately positioned in industry rankings as an ISO 9001:2008 certified company with R&D centers, manufacturing a wide array of pharmaceutical products (tablets, capsules, injections, etc.).
• Davis Morgan LabsminorStrategic or Co-development PartnerAffiliated/sister pharma company in Pax Healthcare's 'Our Divisions' ecosystem; logo featured on the homepage alongside Pax Healthcare's other division partners.
• Aden HealthcareminorStrategic or Co-development PartnerAffiliated/sister pharma company sharing the same SCO-177, Sector 38-C, Chandigarh address as Pax Healthcare. Listed in 'Our Divisions' and in the 'Top PCD Pharma Franchise Companies in Chandigarh' table with an ISO 9001:2015 certification and a gastrointestinal/neurology product focus.
• Acinom HealthcareminorStrategic or Co-development PartnerAffiliated/sister pharma company featured in Pax Healthcare's 'Our Divisions' section on the homepage as part of its pharma ecosystem.
• John Walter LabsminorStrategic or Co-development PartnerAffiliated/sister pharma company featured in Pax Healthcare's 'Our Divisions' section on the homepage as part of its pharma ecosystem.

Scale indicators1 record

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Alkem Laboratories: Top-tier Indian pharma with multiple manufacturing units, generic formulations across therapeutic categories and franchise/C&F distribution; comparable to Pax Healthcare on product breadth and multi-plant model, but at materially larger scale.
• Intas Pharmaceuticals: Large Indian generics and biosimilars player with manufacturing in excise-free zones, broad dosage-form portfolio and PCD franchise distribution; comparable to Pax Healthcare on multi-plant WHO-GMP infrastructure and franchise-led domestic sales.
• Cipla: Major Indian generics manufacturer with strong domestic distribution including franchise and third-party channels; comparable to Pax Healthcare across dosage forms and therapeutic categories, with deeper IP, regulatory and export reach.
• Torrent Pharmaceuticals: Mid-to-large Indian pharma with diversified generics portfolio, multiple manufacturing units and active domestic distribution including franchise channels; comparable to Pax Healthcare on multi-plant manufacturing and franchise-led domestic sales, though with stronger therapeutic specialization.
• Mankind Pharma: One of India's largest pharma companies with an extensive PCD/distribution franchise network across therapeutic categories; comparable to Pax Healthcare in offering monopoly-based franchise rights and a broad generic portfolio, but at vastly greater scale and brand recognition.
• Zydus Lifesciences (Cadila): Diversified Indian pharma major with broad generics, biosimilars and consumer health portfolio, multi-plant WHO-GMP manufacturing and active domestic franchise channel; comparable to Pax Healthcare across dosage-form breadth and franchise GTM, at much larger scale.
• Lupin Limited: Large Indian generics manufacturer with broad therapeutic coverage, WHO-GMP plants, and domestic franchise/C&F distribution; comparable to Pax Healthcare on multi-therapeutic franchise model and manufacturing footprint, though at significantly larger scale.

Direct peers

• Unichem Laboratories: Indian generics manufacturer with WHO-GMP plants, broad dosage-form portfolio and active domestic franchise/PCD distribution; closely comparable to Pax Healthcare in business model (franchise-led domestic generic distribution from own plants), though with stronger API/formulation integration.
• Macleods Pharmaceuticals: Mid-to-large Indian generics manufacturer with a broad multi-therapeutic portfolio and active PCD franchise distribution model; closely comparable to Pax Healthcare in dosage-form breadth, WHO-GMP manufacturing footprint and franchise-led domestic GTM.
• Emcure Pharmaceuticals: Indian pharma company with own manufacturing across formulations, domestic franchise/distribution presence and exports; comparable to Pax Healthcare on multi-dosage manufacturing, domestic franchise GTM and export-led revenue diversification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/_PaxHealthcare_
• Facebookfacebook.com/Pax-Healthcare-100066895816827
• LinkedInlinkedin.com/company/pax-healthcare

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pax Healthcare